Enterprise Value
-6.71M
Cash
12.07M
Avg Qtr Burn
-3.457M
Short % of Float
0.15%
Insider Ownership
9.03%
Institutional Own.
23.19%
Qtr Updated
09/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ALRN-6924 Details Cancer, Breast cancer | Failed Discontinued | |
ALRN-6924 Details Cancer, Non-small cell lung carcinoma | Failed Discontinued | |
ALRN-6924 Details Cancer, Small cell lung cancer, Solid tumor/s | Failed Discontinued |